First report of the prevalence of extended-spectrum β-lactamase producing Escherichia coli in two Mongolian hospitals

Infection, Genetics and Evolution

Volumn 25, Issue , 2014, Pages 66-68

  Kao, Cheng Yen ^a   Udval, Uuganbayar ^b   Wu, Hsiu Mei ^a   Bolormaa, Enkhbaatar ^b   Yan, Jing Jou ^c   Khosbayar, Tulgaa ^b   Wu, Jiunn Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Health Science's University of Mongolia   (Mongolia)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL DNA; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE;

AGAR DIFFUSION; AGAR MEDIUM; AMINO ACID SEQUENCE; AMPC GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM ISOLATION; BLACTX M GENE; BLASHV GENE; BLATEM GENE; DNA SEQUENCE; DOUBLE DISK SYNERGY TEST; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; GYRB GENE; HOSPITAL; LETTER; MDHA GENE; MICROBIAL DIVERSITY; MINIMUM INHIBITORY CONCENTRATION; MONGOLIA; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASE INHIBITORS; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS; HUMANS; MONGOLIA; PHYLOGENY;

EID: 84899866666     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.04.012     Document Type: Letter

References (22)

1. Adwan K., Jarrar N., Abu-Hijleh A.A., Adwan G., Awwad E. Molecular characterization of Escherichia coli isolates from patients with urinary tract infections in Palestine. J. Med. Microbiol. 2014, 63:229-234.
2. Brolund A., Edquist P.J., Makitalo B., Olsson-Liljequist B., Soderblom T., Wisell K.T., Giske C.G. Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden 2007-2011. Clin. Microbiol. Infect. 2013, (Published online: 3 Oct 2013). 10.1111/1469-0691.12413.
3. Chen L.F., Freeman J.T., Nicholson B., Keiger A., Lancaster S., Joyce M., Woods C., Cook E., Adcock L., Louis S., Cromer A.L., Sexton D.J., Anderson D.J. Widespread dissemination of CTX-M 15 genotype extended spectrum beta-lactamase producing Enterobacteriaceae among patients presenting to community hospitals in southeastern United States. Antimicrob. Agents Chemother. 2014, 58:1200-1202.
4. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000, 66:4555-4558.
5. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, 22nd Informational Supplement, M100-S20 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
6. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Canton R., Nordmann P. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 2008, 14:195-200.
7. D'Andrea M.M., Nucleo E., Luzzaro F., Giani T., Migliavacca R., Vailati F., Kroumova V., Pagani L., Rossolini G.M. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob. Agents Chemother. 2006, 50:618-624.
8. Drieux L., Brossier F., Sougakoff W., Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect. 2008, 14(Suppl. 1):90-103.
9. Guenther S., Aschenbrenner K., Stamm I., Bethe A., Semmler T., Stubbe A., Stubbe M., Batsajkhan N., Glupczynski Y., Wieler L.H., Ewers C. Comparable high rates of extended-spectrum-beta-lactamase-producing Escherichia coli in birds of prey from Germany and Mongolia. PLoS One 2012, 7:e53039.
10. Ho P.L., Lo W.U., Lai E.L., Chow K.H., Yam W.C. Escherichia coli O25b-ST131 is an important cause of antimicrobial-resistant infections in women with uncomplicated cystitis. J. Antimicrob. Chemother. 2012, 67:2534-2535.
11. Jiang X., Zhang Z., Li M., Zhou D., Ruan F., Lu Y. Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2006, 50:2990-2995.
12. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 2009, 53:2733-2739.
13. Li B., Sun J.Y., Liu Q.Z., Han L.Z., Huang X.H., Ni Y.X. High prevalence of CTX-M beta-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou. China. Scand. J. Infect. Dis. 2011, 43:170-174.
14. Morrissey I., Hackel M., Badal R., Bouchillon S., Hawser S., Biedenbach D. A review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to 2011. Pharmaceuticals 2013, 6:1335-1346.
15. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Canica M.M., Park Y.J., Lavigne J.P., Pitout J., Johnson J.R. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008, 61:273-281.
16. Oteo J., Perez-Vazquez M., Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 2013, 23:320-326.
17. Park S.H., Byun J.H., Choi S.M., Lee D.G., Kim S.H., Kwon J.C., Park C., Choi J.H., Yoo J.H. Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect. Dis. 2012, 12:149.
18. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002, 40:2153-2162.
19. Qin X., Hu F., Wu S., Ye X., Zhu D., Zhang Y., Wang M. Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains. PLoS One 2013, 8:e61169.
20. Tartof S.Y., Solberg O.D., Manges A.R., Riley L.W. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J. Clin. Microbiol. 2005, 43:5860-5864.
21. Wu C.J., Chuang Y.C., Lee M.F., Lee C.C., Lee H.C., Lee N.Y., Chang C.M., Chen P.L., Lin Y.T., Yan J.J., Ko W.C. Bacteremia due to extended-spectrum-beta-lactamase-producing Aeromonas spp. at a medical center in southern Taiwan. Antimicrob. Agents Chemother. 2011, 55:5813-5818.
22. Yan J.J., Ko W.C., Tsai S.H., Wu H.M., Jin Y.T., Wu J.J. Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J. Clin. Microbiol. 2000, 38:4320-4325.